SecondWave Systems is a clinical-stage medical device company focused on creating noninvasive ultrasound therapies for inflammatory disorders. Its flagship product, the SecondWave MINI™, is a first-of-its-kind wearable device that uses proprietary ultrasound technology to stimulate the spleen and modulate inflammatory responses. The company aims to offer patients and physicians a new option for managing acute and chronic inflammation, including conditions such as rheumatoid arthritis. Current efforts center on clinical studies to validate the platform’s safety and efficacy across multiple inflammatory indications. Proceeds from its ongoing financing will accelerate product development, clinical trials, and eventual commercialization. Based in St. Paul, Minnesota, SecondWave collaborates with an experienced syndicate of medical-technology investors to bring its therapy to market. No revenue or user metrics have been disclosed, reflecting the company’s pre-commercial stage of operations.

Total raised

$11M

Funding rounds

3

Latest round

Series A

Latest activity

Apr 2025